Mark J Foley - Net Worth and Insider Trading
Mark J Foley Net Worth
The estimated net worth of Mark J Foley is at least $21 Million dollars as of 2024-11-13. Mark J Foley is the President and CEO of ZELTIQ Aesthetics Inc and owns about 211,454 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $12 Million. Mark J Foley is the Director of Glaukos Corp and owns about 33,220 shares of Glaukos Corp (GKOS) stock worth over $5 Million. Mark J Foley is also the CEO of Revance Therapeutics Inc and owns about 1,126,381 shares of Revance Therapeutics Inc (RVNC) stock worth over $5 Million. Details can be seen in Mark J Foley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Foley has not made any transactions after 2024-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J Foley
Mark J Foley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Foley owns 4 companies in total, including Revance Therapeutics Inc (RVNC) , SI-BONE Inc (SIBN) , and Glaukos Corp (GKOS) among others .
Click here to see the complete history of Mark J Foley’s form 4 insider trades.
Insider Ownership Summary of Mark J Foley
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RVNC | Revance Therapeutics Inc | 2024-03-06 | director |
SIBN | SI-BONE Inc | 2019-06-13 | director |
GKOS | Glaukos Corp | 2024-02-23 | director |
2017-04-28 | director & President and CEO |
Mark J Foley Latest Holdings Summary
Mark J Foley currently owns a total of 3 stocks. Among these stocks, Mark J Foley owns 211,454 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of March 13, 2017, with a value of $12 Million and a weighting of 55.9%. Mark J Foley owns 33,220 shares of Glaukos Corp (GKOS) as of February 23, 2024, with a value of $5 Million and a weighting of 22.33%. Mark J Foley also owns 1,126,381 shares of Revance Therapeutics Inc (RVNC) as of March 6, 2024, with a value of $5 Million and a weighting of 21.77%.
Latest Holdings of Mark J Foley
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZLTQ | ZELTIQ Aesthetics Inc | 2017-03-13 | 211,454 | 56.48 | 11,942,922 |
GKOS | Glaukos Corp | 2024-02-23 | 33,220 | 143.63 | 4,771,389 |
RVNC | Revance Therapeutics Inc | 2024-03-06 | 1,126,381 | 4.13 | 4,651,954 |
Holding Weightings of Mark J Foley
Mark J Foley Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Foley has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 10,000 shares on March 13, 2017, which brought Mark J Foley around $557,700.
According to the SEC Form 4 filings, Mark J Foley has made a total of 1 transactions in Glaukos Corp (GKOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Glaukos Corp is the sale of 4,560 shares on February 23, 2024, which brought Mark J Foley around $423,487.
According to the SEC Form 4 filings, Mark J Foley has made a total of 7 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in Revance Therapeutics Inc is the acquisition of 30,000 shares on March 6, 2024, which cost Mark J Foley around $209,400.
Insider Trading History of Mark J Foley
- 1
Mark J Foley Trading Performance
GuruFocus tracks the stock performance after each of Mark J Foley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Foley is -6.03%. GuruFocus also compares Mark J Foley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Foley within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark J Foley's insider trading performs compared to the benchmark.
Mark J Foley Ownership Network
Ownership Network List of Mark J Foley
Ownership Network Relation of Mark J Foley
Mark J Foley Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Mark J Foley is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Mark J Foley made 5 insider transaction in Revance Therapeutics Inc (RVNC) with a net sale of 124,284. Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 35,664 shares made by Tobin Schilke , a net sale of 64,379 shares made by Dwight Moxie , and a net sale of 35,226 shares made by Dustin S Sjuts .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Mark J Foley Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Foley. You might contact Mark J Foley via mailing address: Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton Ca 94588.